CareKinesis is the first national PACE-centric, medication management and distribution pharmacy that focuses on reducing medication-related risk while enhancing economic, clinical, and humanistic outcomes.

24/7 PharmD

Helpful PharmDs trained in geriatric prescribing are available 24 hours a day, 7 days a week to help reduce medication-related risks and reduce total medication costs.

Learn more >

Adherence PackagingAdherence

Medications are robotically dispensed into special adherence packaging, organized by days and dosage times, increasing participant adherence.

Learn more >

Web Portal

Real-time medication profiles, dispensing and delivery information, secure pharmacy messaging, robust reporting, and operations software.

Learn more >

PDE Report
Submission Support

Submission of PDE data and monthly utilization reports. For PBM-contracted organization, CareKinesis adjudicates claims as a network pharmacy.

Learn more >

Featured News

Results of Tabula Rasa HealthCare’s First Simulated Clinical Study on Proposed COVID-19 Treatments and Therapies is Published

MOORESTOWN, NJ, (August 12, 2020) – Tabula Rasa HealthCare, Inc® (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, announces TRHC’s Precision Pharmacotherapy Research and Development Institute (PPRDI) published the research article, “Risk of Adverse Drug Events Following the Virtual Addition of COVID-19 Repurposed Drugs to Drug Regimens of Frail Older Adults with Polypharmacy”, in the August 10, 2020, online edition of the Journal of Clinical Medicine. The article is a result of the first U.S. simulation study conducted in an outpatient setting to assess the estimated risk of adverse drug events (ADEs) with repurposed COVID-19 treatments.